Third party funding

Third Party Funding

• DFG SFB_TR36
• German Center for Infection Research (DZIF)
• Helmholtz Alliances “Immunotherapy of Cancer” and „Synthetic Biology“
• Helmholtz-Alberta Initiative on Infection Research
• Helmholtz Validation Fond
• Innovation Funds, Federal Ministry for Economic Affairs Germany

Industry research collaborations:

• Roche Inc., Paolo Alto, CA, USA
• Janssen Pharmaceutica, Beerse, Belgium
• GILEAD Sciences, Foster City, USA
• Leukocare, Munich
• Rheinbiotech – Dynavax Europe, Düsseldorf, Germany

Leider ist der Eintrag nur auf English verfügbar.